ESC 365 - Regnase-1 overexpression as a novel gene therapy approach for pulmonary hypertension

ESC Professional Premium Access

Regnase-1 overexpression as a novel gene therapy approach for pulmonary hypertension

Session: New insights and therapeutic options in pulmonary arterial hypertension

Topic: Hypertension, Pulmonary Hypertension

Speaker: Doctor A. Remes (Kiel, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Anca Remes

Christian-Albrechts-University Kiel, Kiel (Germany)

0 follower

6 more presentations in this session

Focused ultrasound stimulation of the inflammatory reflex at the spleen ameliorates pulmonary arterial hypertension in rodents

Speaker: Doctor S. Zafeiropoulos (Zurich, CH)

A miRNA derived from the 17/92 cluster is a novel player in programming pulmonary hypertension in response to gestational hypoxia via NADPH oxidases and the mTOR pathway

Speaker: Ms Y. Qin (Munich, DE)

AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 212 knock-in mice

Speaker: Mr Y. Chou (New Taipei, TW)

Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease

Speaker: Mr S. Huertas Nieto (Santa Cruz de Tenerife, ES)

Transcriptomic profiling reveals connection to lung autonomic nervous system dysfunction and inflammation in pulmonary artery hypertension rats

Speaker: Doctor T. Tan (Wuhan, CN)

Access the full session

New insights and therapeutic options in pulmonary arterial hypertension

Speakers: Doctor A. Remes, Doctor S. Zafeiropoulos, Ms Y. Qin, Mr Y. Chou, Mr S. Huertas Nieto...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources